HEMOSHEAR THERAPEUTICS, LLC

Profile

Company Names

HEMOSHEAR THERAPEUTICS, LLC
HEMOSHEAR LLC

Addresses

501 LOCUST AVENUE, SUITE 301, CHARLOTTESVILLE, VA 22902

1115 5TH STREET S.W., CHARLOTTESVILLE, VA 22902

Phone Numbers

434-872-0196
434-760-2720

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

VA

Total Amount Raised:

$8,899,974.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2020-02-05 
$2,281,000.00 
$4,000,000.00 
$1,719,000.00 
 
7
2018-07-31 
$200,000.00 
$200,000.00 
$0.00 
Equity 
6
2017-05-15 
$800,000.00 
$5,000,000.00 
$4,200,000.00 
Debt 
5
2016-01-19 
$2,640,562.00 
$20,000,000.00 
$17,359,438.00 
Equity 
4
2013-10-20 
$2,528,412.00 
$4,000,000.00 
$1,471,588.00 
Equity 
3
2012-03-26 
$50,000.00 
$5,000,000.00 
$4,950,000.00 
Equity 
2
2010-09-02 
$250,000.00 
$8,000,000.00 
$7,750,000.00 
Equity 
1
2009-04-07 
$150,000.00 
$4,500,000.00 
$4,350,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
VINCENT 
E. 
AURENTZ 
EXECUTIVE OFFICER
HEMOSHEAR LLC
BRETT 
R. 
BLACKMAN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HEMOSHEAR LLC
JOHN 
L. 
BROOKS, III 
DIRECTOR
HEMOSHEAR LLC   |  HEMOSHEAR THERAPEUTICS, LLC
FREDERICK 
W. K. 
BROWN 
DIRECTOR
HEMOSHEAR LLC
BRIAN 
M. 
CAMPBELL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HEMOSHEAR LLC
ROBERT 
 
GOULD 
DIRECTOR
FULCRUM THERAPEUTICS, INC.   |  HEMOSHEAR THERAPEUTICS, LLC   |  TURNSTONE BIOLOGICS CORP.   |  FAETH THERAPEUTICS, INC.   |  SPINNAKER LINCOLN PARK LLC
ROBERT 
J. 
GOULD 
DIRECTOR
HEMOSHEAR THERAPEUTICS, LLC   |  HEMOSHEAR THERAPEUTICS, INC.
NICOLE 
E. 
HASTINGS 
EXECUTIVE OFFICER
HEMOSHEAR LLC
MARK 
 
HAYES 
EXECUTIVE OFFICER
SINGLEPIPE, INC.   |  COUNTRY CLUB OF GREENVILLE, LLC   |  HEMOSHEAR THERAPEUTICS, LLC   |  BRIDGE SOUTH CAPITAL FUND LLC
ARIC 
 
HOLSINGER 
EXECUTIVE OFFICER
EPALS INC   |  EPALS CORP   |  CRICKET MEDIA GROUP LTD.   |  CRICKET MEDIA HOLDINGS, INC.   |  HEMOSHEAR THERAPEUTICS, LLC   |  HEMOSHEAR THERAPEUTICS, INC.
BRIAN 
A. 
JOHNS 
EXECUTIVE OFFICER
HEMOSHEAR THERAPEUTICS, LLC   |  HEMOSHEAR THERAPEUTICS, INC.
MEHMOOD 
A. 
KHAN 
DIRECTOR
HEMOSHEAR LLC   |  HEMOSHEAR THERAPEUTICS, LLC
KATHLEEN 
M. 
METTERS 
DIRECTOR
LYCERA CORP   |  HEMOSHEAR THERAPEUTICS, LLC   |  HEMOSHEAR THERAPEUTICS, INC.   |  ASLAN PHARMACEUTICALS LTD
JAMES 
C. 
POWERS 
EXECUTIVE OFFICER, DIRECTOR
HEMOSHEAR LLC   |  GENE SOLUTIONS LLC   |  HEMOSHEAR THERAPEUTICS, LLC   |  HEMOSHEAR THERAPEUTICS, INC.
SANDRA 
 
ROJAS-CARO 
EXECUTIVE OFFICER
HEMOSHEAR THERAPEUTICS, LLC
JONATHAN 
M. 
SACKIER 
DIRECTOR
HEMOSHEAR LLC   |  NOVATRACT SURGICAL, INC.   |  HELIUS MEDICAL TECHNOLOGIES, INC.
W. 
MCILWAINE 
THOMPSON, JR. 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HEMOSHEAR LLC
WILLIAM 
MCILWAINE 
THOMPSON, JR. 
EXECUTIVE OFFICER
TEARSOLUTIONS, INC.   |  HEMOSHEAR THERAPEUTICS, LLC
BRIAN 
R. 
WAMHOFF 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
HEMOSHEAR LLC   |  HEMOSHEAR THERAPEUTICS, LLC
H. 
THOMAS 
WATKINS 
DIRECTOR
CONJUGON INC   |  HEMOSHEAR THERAPEUTICS, LLC
H. 
THOMAS 
WATKINS, III 
DIRECTOR
HEMOSHEAR THERAPEUTICS, LLC
RICHARD 
O. 
WHITE 
EXECUTIVE OFFICER
HEMOSHEAR LLC   |  HEMOSHEAR THERAPEUTICS, LLC
REGINALD 
F. 
WOODS 
DIRECTOR, PROMOTER
HEMOSHEAR LLC   |  HEMOSHEAR THERAPEUTICS, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-02-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-02-05 
2018-08-14
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
2017-06-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-15 
2017-05-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-05-15 
2017-04-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-01-19 
2014-01-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-10-20 
2012-04-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-26 
2010-09-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-09-02 
2009-04-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-07 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#